Study Claims Marijuana Can Treat âADHDâ
A small study of 30 participants in Germany claims that cannabis can be used to treat âADHDâ because it increases the availability of dopamine. "This then has the same effect but is a different mechanism of action than stimulants like Ritalin and dexedrine amphetamine, which act by binding to the dopamine and interfering with the metabolic breakdown of dopamine." According to the report, 22 of the 30 participants opted to discontinue their prescriptions in favor of medical marijuana.
Podcast: The Top 10 Quotes of 2017
In this podcast for HealthNewsReview.org, Michael Joyce shares what he considers the 10 most compelling quotes from last year's podcast episodes. The quotes include a wide variety...
Multisystemic Therapy No More Effective than Standard Care for Antisocial Behavior
Study counters previous evidence supporting multisystemic therapy, finding adolescents are just as likely to have out-of-home placements when receiving multisystemic therapy versus management as usual.
Mental Health is Different for People of Color in These 3 Ways
In this piece for Rest for Resistance, Dom Chatterjee discusses the white-centricism of mental health as well as the specific ways that the mental health system...
âThe Impact of Shift Work on Healthâ
Medical News Today provides an overview of the research on the effects of shift work on the physical and mental well-being of employees. "Although...
‘ADHD’ and Dangerous Driving
In former times, children who were routinely inattentive and impulsive were considered to be in need of training and discipline. By and large, school teachers and parents provided this. In fact, the training was usually provided before the matter even became an issue. Today these children are spuriously and arbitrarily labeled as ill, and are given pills. At the present time the pharma-psychiatric system is being widely exposed as the spurious, destructive, disempowering fraud that it is. Organized psychiatry is responding to these criticisms not by cleaning up its act, but instead by increasing its lobbying activity in the political arena.
Cultural Confusion: The Shifting Line Between Sane and “Unsane”
From STAT: An unprecedented number of Americans have been diagnosed with a mental, behavioral, or emotional disorder. Does this represent an increase in psychological distress...
Billion Dollar Deals and How They Changed Your World
A new BBC documentary, "Health," investigates the deals struck between health professionals and pharmaceutical companies. The documentary includes an interview with Dr. James Davies, co-founder of the...
Selling Adult ADHD: NPR Coverage Helps Advance Drug Industry
From HealthNewsReview: NPR recently reported on a study claiming that a test of just six simple questions can reliably diagnose adults with ADHD. Unknown to...
“No Evidence Ritalin Makes a Difference Long Term for ADHD Kids”
The Sydney Morning Herald reports that, three years into an Australian study that is following 178 children with ADHD and 212 children without ADHD, the...
ADHD Medication Use Rising Dramatically, Especially Adults
A report released today by Express Scripts, the nation's largest prescription drug manager, offers "the most current and comprehensive analysis of ADHD medication use"...
Four-Part Series on Drug Abuse, Trauma, and How to Heal It
In this four-part series on drug abuse and trauma, Parents Opposed to Pot provides an overview of the impact of adverse childhood experiences, how they persist, and...
Researchers Canât Predict Whether Childhood ADHD Will Impact Adult Functioning
New research has found that a childhood ADHD diagnosis is not predictive of adult functioning in boys.
ADHD and “The Merchants of Speed”
Pediatrician and UCSF professor Lawrence Diller has issued the fourth of a four-part memoir on Huffington Post, recounting the rise of ADHD medicating and...
“Heal the Artists, Save the World”
Kelly Brogan, MD, writes: "Maybe your depression, chronic fatigue, ADHD, and chemical sensitivity are just ways that your body, mind, and soul, are saying no....
âThe Hefty Price of âStudy Drugsâ Misuse on College Campusesâ
For the Conversation, Binghamton University researcher Lina Begdache tackles the issue of the growing use of 'Study Drugs' in the student population. âAnimal studies show...
“A Generation of Stimulation Junkies: Television, ADD and ADHD”
Mod Vive reports that "The rampant self-diagnosing of attention deficit-hyperactivity disorder (ADHD) is out of control. There is also an increasing amount of people...
The Surprising Science of Fidgeting
In this piece for The Conversation, Harriet Dempsey-Jones provides a variety of possible explanations for why we fidget, as well as the increasing popularity of...
Students Sue Oxford University for Mental Health Discrimination
From Express: Catherine Dance, a 24-year-old law graduate, is suing Oxford University's Jesus College for refusing to grant accommodations for her mental health disability and forcing...
“ADHD treatment market value to reach $9.9 bn by 2020”
According to business intelligence firm GBI Research, the ADHD medication market will rise in value from $6.9 billion in 2013 to $9.9 billion by...
‘A Little Bit of OCD’: The Downside of Mental Health Awareness
From The Guardian: People often claim to experience mental health problems only to excuse their unpleasant or hurtful behaviors. This can exacerbate prejudice toward those...
Disturbed Sleep Patterns May be Key to ADHD
From The Guardian: New research has linked symptoms of ADHD, such as struggling to concentrate, having too much energy, and being unable to control behavior,...
‘Take Your Pills’ is a Fascinating Look at the Adderall Craze
From The Michigan Daily: Netflix's new documentary "Take Your Pills" examines the historical, cultural, social, and systemic factors that have shaped the ever-increasing rates of...
Is The Microbiome our Puppeteer?
âMy message today is that your state of gut will affect your state of mind. To have a healthy brain, we may need a...
Questions Remain About New “Smart Drug” Modafinil Safety
A number of news outlets have been reporting on a review of modafinil, labeled the new "smart drug," this week. The review in question summarized the recent literature on the drug but others have claimed that the authors underestimated potential side-effects.